PlainRecalls
FDA Drug Low Class III Terminated

Excedrin, Sinus Headache, Acetaminophen 325mg, Phenylephrine HCL 5mg , 2 caplets. Distributed by: Novartis Consumer Health, Inc., Parsippany, NJ. 07054-0622, NDC 0067-2062-02.

Reported: January 22, 2014 Initiated: May 15, 2013 #D-744-2014

Product Description

Excedrin, Sinus Headache, Acetaminophen 325mg, Phenylephrine HCL 5mg , 2 caplets. Distributed by: Novartis Consumer Health, Inc., Parsippany, NJ. 07054-0622, NDC 0067-2062-02.

Reason for Recall

Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing

Details

Recalling Firm
Novartis Consumer Health
Units Affected
2,978,000/2-caplet packages
Distribution
Distribution was made nationwide and foriegn distribution was made--Mexicio, Panama, Ecuador and Venezuela.
Location
Lincoln, NE

Frequently Asked Questions

What product was recalled?
Excedrin, Sinus Headache, Acetaminophen 325mg, Phenylephrine HCL 5mg , 2 caplets. Distributed by: Novartis Consumer Health, Inc., Parsippany, NJ. 07054-0622, NDC 0067-2062-02.. Recalled by Novartis Consumer Health. Units affected: 2,978,000/2-caplet packages.
Why was this product recalled?
Failed Impurities/Degradation:Specifications:Unknown degradant found during stability testing
Which agency issued this recall?
This recall was issued by the FDA Drug on January 22, 2014. Severity: Low. Recall number: D-744-2014.